BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21051091)

  • 1. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
    Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
    Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
    Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
    Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model.
    Yu WY; Chuang TF; Guichard C; El-Garch H; Tierny D; Laio AT; Lin CS; Chiou KH; Tsai CL; Liu CH; Li WC; Fischer L; Chu RM
    Vaccine; 2011 Apr; 29(18):3489-500. PubMed ID: 21392590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
    Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
    [No Abstract]   [Full Text] [Related]  

  • 7. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.
    Bird RC; Deinnocentes P; Lenz S; Thacker EE; Curiel DT; Smith BF
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):289-304. PubMed ID: 18423623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation characteristics of canine transmissible venereal tumor.
    Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
    Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
    do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
    Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
    Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
    Scarpelli KC; Valladão ML; Metze K
    Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
    Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
    Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic potential of three transmissible venereal tumor cell lysates to prime canine-dendritic cells for cancer immunotherapy.
    Hernández-Granados AJ; Franco-Molina MA; Coronado-Cerda EE; Zapata-Benavides P; Gamboa EM; Ramos-Zayas Y; Santana-Krímskaya SE; Rodríguez-Padilla C
    Res Vet Sci; 2018 Dec; 121():23-30. PubMed ID: 30316013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor immunity derived from a novel vaccine of fusion hybrid between dendritic and engineered myeloma cells.
    Hao S; Bi X; Xu S; Wei Y; Wu X; Guo X; Carlsen S; Xiang J
    Exp Oncol; 2004 Dec; 26(4):300-6. PubMed ID: 15627063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.